Winners Supplement

7
The Award Winners 2017
The Banking Hall, London

3 March 2017
Sponsored by
PERFECTUS
BIOMED
© 2017 MA Healthcare Ltd
All rights reserved. No reproduction, transmission or copying of this publication is allowed without written
permission. No part of this publication may be reproduced, stored in a retrieval system, or transmitted
in any form or by any means, mechanical, electronic, photocopying, recording, or otherwise, without the
prior written permission of MA Healthcare Ltd or in accordance with the relevant copyright legislation.
Although the editor and MA Healthcare Ltd have taken great care to ensure accuracy, MA Healthcare Ltd
will not be liable for any errors of omission or inaccuracies in this publication.
Printed by: Pensord, Blackwood, Newport, Wales, UK
Published by: MA Healthcare Ltd, St Jude’s Church, Dulwich Road, London SE24 0PB, UK
Tel: +44 (0)20 7738 6726 Email: anthony.kerr@markallengroup.com Web: www.markallengroup.com
2 JWC The Awards 2017

7
Contents
Forward5
Wound Assessment and Diagnostics 6
Effective Wound Bed Preparation, Infection and Biofilm 8
Cost-effective Wound Management 10
Pressure Care 11
Innovation in North America 12
Best Laboratory/Preclinical Study 14
Clinical Research 18
Patient Wellbeing 20
Compression Therapy for Venous and Lymphatic Disorders 22
Professional Education 23
Innovation24
Veteran and Military Wound Care 26
Innovative New Dressing 28
Innovative New Product 29
Best Research in a Developing Country 30
JWC The Awards 2017 3

Choose the right
subscription for you
 FULL CLUB
 DIGITAL CLUB
 PRINT EDITION
 DIGITAL EDITION
volume 25. number 10. october 2016
 ONLINE ARCHIVE
Official journal of the World Union of Wound Healing Societies
MEDLINE
LISTED
IMPACT
FACTOR
The role of resilience in rebuilding lives

of injured veterans
Impact of surgical wound dehiscence on health-related QoL and mental health
A thoracoabdominal necrotising soft tissue infection: a case study
Antibacterial properties and reduction of MRSA biofilm with a novel dressing
Effectiveness of hyaluronic acid and its derivatives on chronic wounds
JoWC_2016_25_10_cover.indd 1 20/09/2016 16:38
THE ONLY MONTHLY INTERNATIONAL JOURNAL OF WOUND CARE
ORIGINAL EVIDENCE-BASED PROSPECTIVE LATEST

RESEARCH PRACTICE STUDIES DEVELOPMENTS
Expert peer-reviewed Clinical case studies and In-depth studies of new All the innovations in
research covering all nursing articles designed treatment applications wound care from both
aspects of wound care, to help you deal with with research into existing preclinical and preliminary
carefully selected to raise complex wounds and treatments to guide your clinical trials of potential
standards of patient care improve your practice clinical decision-making treatments worldwide
Visit www.magsubscriptions.com/jwc or call 0800 137 201 (UK ONLY)

7 Foreword
On Friday 3rd March 2017 we held the fifth annual Journal
of Wound Care (JWC) awards in London, to celebrate and pay
tribute to innovation and excellence in wound care research and
practice worldwide. Five years after the inaugural awards and the
standard and number of nominations continues to increase.
This year’s ceremony, held at the prestigious Banking Hall,

were a resounding success. We were particularly pleased to
introduce three new awards. For the first time we presented two
categories specifically for industry, Innovative New Dressing
and Innovative New Product, both celebrating the most up-
to-date and exciting technologies in their respective fields. We
also introduced the Innovation in North America award, in
conjunction with the JWC North American supplement. This
was a highly contested, with the shortlisted nominees working
in very different fields and all very deserving of the award.
For this year’s 15 categories we received a record number of

entries from more than 10 countries. For each category, the
top three entrants were shortlisted with the help of judges
from the JWC editorial board and other wound-care experts.
The night was attended by tissue viability nurses, clinicians,
scientists and academics, travelling from countries all over
the world including, the US, Czech Republic, Ireland and
Canada. Glamorous outfits filled the majestic atmosphere and
surroundings of the historic Banking Hall, where the evening
was expertly hosted by comedian and BBC regular, Ian Moore.
Congratulations to all the well-deserved winners on the night and

also to those shortlisted among such strong competition. This
showcase of wound care practice and research initiatives gives an
opportunity to share experience and achievements and for the
first time, this year’s special JWC Awards supplement contains
details of the second and third place winners. The hard work
that nurses, clinicians, scientists and researchers contribute to
improving the lives of patients with wounds, and their dedication
and enthusiasm towards their work is inspirational. We hope
that by reading these pages you will be inspired and who knows,
maybe you will be on the podium at the JWC awards 2018.
I hope to see you all there.
Dr Rachel Webb
Editor, Journal of Wound Care

Wound Assessment and Diagnostics
Sponsored by
Michelle Deeth
Head of Clinical Services North, Urgo Medical UK
Why did you support this award?

Urgo was committed to supporting this category as wound assessment is essential to
achieving the outcomes that patients deserve. With the introduction of the new wound
assessment Search Results Commissioning for Quality and Innovation (CQUIN) this will
be a priority area within wound care and a key focus for those clinicians working within
tissue viability. An holistic assessment, accurate diagnosis and thorough documentation
are essential for wounds to be effectively treated. An understanding of the genesis of the
wound can be gained from the wounds’ clinical signs and the investigations completed.
What do you think defines excellence in wound care?

Excellence in wound care is ensuring that patients are involved in their care, outcomes are
achieved and the wound heals within the normal healing trajectory. The care should be
delivered by the right person, at the right time and it is appropriate to the stage of healing
and the tissue type within the wound bed. To excel in wound care the clinician must have
the knowledge and skills to understand the wound, how to complete an assessment and the
ability to interpret the evidence and implement best practice.
How do you think this award will impact practice and research in wound care?
Wound assessment is an area in wound care that cannot be ignored. I feel sure that due
to the CQUIN we will start to see the emergence of more pathways, greater evidence-
based care, which is driven by patient focused research. Patients are also taking greater
responsibility for their care, questioning practice and challenging the evidence. This award
will raise the profile of wound assessment, advances in treatment and clinical developments.
How does this award change people’s perception of the role of wound assessment and
diagnostics in wound care?
It keeps wound assessment and diagnostics high on the tissue viability agenda. It is a useful
platform for sharing best practice and demonstrates the good work that is being done
within this important area of care.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
Be bold and brave! Don’t be afraid to challenge the norm. Generate the evidence, share it
and use it for the benefit of the patient.

7
WINNER
Chris Murphy
CEO, Bluedrop Medical
Describe the work you have done, which has resulted in you winning a JWC award
Up to 25% of patients with diabetes will develop a foot ulcer at some point in their life.
These ulcers often take months to heal and if not treated early can result in amputation and
may even be life threatening. Bluedrop Medical is developing a device that takes a daily scan
of the soles of a diabetic patient’s feet, taking the form of a bathroom scales. The user steps
on the device once a day for 20 seconds. The information collected is reviewed using advanced algorithms and
clinical reviewers. If an active ulcer or the pre-signs of ulceration are detected the patient and their clinician are
notified, allowing for the earliest possible intervention. Prevention of diabetic foot ulcers would result in more
time for clinicians to devote to treating wounds that do occur as well as focusing on other prevention and risk
reduction strategies such as debridement, pressure offloading and education. This would have a further effect of
reduction in the rate of ulceration.
How do you think winning this award will affect your work in the future?
To be chosen as a winner in two categories by a prominent panel of expert judges, representative of the diversity of
disciplines and organisations that make up the wound care sector is a huge honour. We are grateful to receive these
awards and see them as an acknowledgement of the way in which our team continually strive to develop solutions
that benefit both patients and the healthcare system as a whole. It also reflects the increased awareness in the
clinical community of the need for increased efforts to prevent these devastating ulcers before they develop.
What do you most enjoy about your work?

The fact that Bluedrop Medical is developing a product that could be life changing for the millions of patients with
diabetes at high risk of developing ulcers around the world.
SECOND PLACE THIRD PLACE

Andrea Pokorná, Leanne Atkin and Joy Tickle
Associate Professor, Masaryk Vascular Nurse Specialist, Mid Yorkshire NHS
University, Czech Republic Trust and Tissue Viability Nurse, Shropshire
Community Health
Accurate assessment of the chronic wounds is essential Atkin and Tickle formulated a treatment algorithm for lower
and primary step in diagnosis. Although it is known that the leg ulceration which was adopted as a Best Practice Statement
centralised use of evidence is beneficial, there is no uniform for leg ulcer management. The algorithm simplified the
system or recommendations for assessment of patient’s diagnosis and selection of appropriate compression therapy for
wounds in the Czech Republic in both acute and residential patients. It stressed the importance of appropriate diagnosis
social care. An effective strategy for wound management and linked this to a treatment pathway, emphasising the
depends on the method and scope of the assessment of non- requirement for diagnostic testing to ensure practice is safe.
healing observed. I helped prepare and introduce an algorithm,
‘non-healing, chronic wound assessment, in the Czech Republic
and we are expecting improvements to follow.

Effective Wound Bed Preparation, Infection an
Sponsored by
Karen Woosey
Marketing Director, PAUL HARTMANN Ltd
HARTMANN is delighted to have supported this important award around effective wound
bed preparation, specifically relating to the roles of infection and biofilm. There is growing
evidence that good tissue hydration may be the most important external factor responsible
for optimal wound healing. We are excited to have launched two innovative hydro-
responsive wound dressings (HRWD), HydroClean plus and HydroTac. These are unique
products that facilitate optimal wound bed preparation and help keep wounds in a balanced
moist environment, therefore optimising healing efficiency.
Why is it important for the JWC to recognise excellence through the Wound Bed
Preparation, Infection and Biofilm award?
The current financial crisis and rising costs of services, along with higher patient numbers
to care for, all spell out a huge challenge for all involved in the management and care of
patients with wounds. Effective wound bed preparation can lead to faster healing times and
a reduction in the occurrence of critical colonisation/infection, thereby reducing treatment
time and costs.

Excellence is defined as ‘the state or quality of excelling or being exceptionally good’. In
wound care this should relate to the treatment of the patient and their wounds, both
through the actions and applied knowledge of the clinician, supported by the best available
therapies that can be used and by evidence-based medicine.
Recognising the achievements of clinicians and scientists in wound care will inspire and
motivate other workers involved in the field to strive for better patient outcomes.
How has this award changed people’s perception of the role of infection and biofilm
research in wound care?
Knowledge and understanding comes before action. Communicating and educating wound
care health professionals about the role of infection and biofilm, provides a bedrock on
which better treatments and patient outcomes can be based.
Enabling change can sometimes be difficult, especially in a discipline such as wound care
that suffers lack of funding and a low priority profile in medicine. But the objectives of
achieving positive change are the same in all aspects of medicine and relate for the most
part to better patient outcomes. Having the mind set of achieving this goal is probably the
most important aspect in getting there.

nd Biofilm 7
WINNER
Jennifer Hurlow & Jennifer Gaddy
Canterbury Christ Church University Center and Vanderbilt
University Medical
Please describe the work you have done which resulted in you winning a JWC award.
The aim of our study was to analyse wound biofilm from a clinical perspective. This required the
establishment of a link between the clinical setting and the microscopic laboratory. A clinical
algorithm for biofilm identification was used to choose macroscopic wound samples; 75% of these
samples were confirmed by advanced microscopy to contain biofilm despite the use of modern
antiseptic wound dressings and, in some cases, systemic antibiotics. It was found that adherence to
the biofilm based wound care (BBWC) paradigm was difficult in the outpatient setting.
It confirms interest in our findings. Biofilm is accepted to be a roadblock to wound healing. The realisation that many current wound
care strategies are ineffective in managing biofilm will motivate future work to clarify related implications.
How has winning this award changed people’s perception of your role?
We hope that the recognition of our research will encourage others to establish a link between the scientific laboratory and the
clinical wound care setting. This link creates the potential to clarify long held assumptions which will allow wound science to advance.
What is the most important aspect of your work and why?

We have shown that wound biofilm can reach a macroscopic state in a short period of time. We have provided support for the
validity of a clinical algorithm developed to help clinicians identify wound biofilm. These confirmed visual cues will enhance provider
ability to choose the most cost-effective treatment strategy.
What are the main challenges you face?

I was fortunate to find the willing expertise of my Vanderbilt colleagues. My prolonged search was finally successful after receiving
assistance from a microscopist at Central Michigan University, US.

Matthew Malone Matthew Malone
Liverpool Hospital Sydney, Australia Liverpool Hospital, Sydney, Australia
Use of molecular biology techniques to see the effects Use of molecular biology techniques to confirm the
of anantimicrobial on biofilm in vivo presence of biofilm in diabetic foot ulcers
Malone and team used a series of molecular and microscopy The evidence for the presence of biofilm in diabetic foot ulcers
approaches to examine the effects of antimicrobials on (DFUs) is poor. Malone and team completed a prospective
biofilm in vivo. Their results showed cadexomer iodine can study enrolling 65 DFUs, identifying biofilm in all of these
reduce biofilm in vivo. They further identified that where the wounds using a number of molecular techniques. This provided
treatment failed the wounds contained unusual microbes that robust data confirming biofilm are ubiquitous in DFUs and that
appeared capable of resisting iodine treatment. clinicians should focus on performing biofilm-based wound
care approaches.

Cost-effective Wound Management
WINNER
Kumaresan Nagarajan and
Cardiothoracic Surgical Team
New Cross Hospital Wolverhampton
Describe the work you have done which resulted in you winning a JWC award.
Minimal invasive techniques have become the benchmark of progression in the last decade.
Embracing this in the tumultuous NHS climate and proving ourselves was a big challenge.
Coronary artery bypass surgery is the most common cardiac procedure with saphenous vein harvest having the longest incision
in all surgical procedures. Endoscopic vein harvest has improved patient recovery with reduced length of hospital stay and drastic
reduction in leg wound infection. We were able to successfully prove significant saving despite the cost of harvest kit.
This award will vindicate our team’s belief of embracing progress and implementing it to optimise patient care. This would help us gain
funding for future projects. The research this enabled will generate evidence templates for future advances in cardiothoracic surgery.
This award will garner respect within our trust and the region. Our cardiothoracic team at New Cross, Wolverhampton currently
stands second in having the lowest mortality rate across UK. This would help us in proclaiming our progress.

The implementation of new technology is always difficult. I have learnt a lot from educating staff about new technological advances
to placing forward business cases to obtain necessary funding to diligent data collection, enabling demonstration of evidence
required for further progress to achieving work-life balance.

High Risk Podiatry Team Deborah Gleeson
Diabetes Centre, Cwm Taf UHB and team
The High Risk Podiatry team in Cwm Taf UHB have
Lead Nurse Tissue Viability, St Helens and
implemented a podiatry-led, multicentred, total contact Knowsley NHS Trust
casting (TCC) service for neuropathic diabetic foot ulcers
(DFUs). The implementation of TCC has reduced the average Between 2011 and 2015, St Helens and Knowsley Teaching
wound healing time to 35 days versus the reported average Hospitals NHS Trust evaluated low-friction bootees integrated
of between 75–133 days in alternative offloading devices. This into the care path for patients at-risk of heal pressure ulcers to
reduction the healing time of DFUs has huge financial benefits reduce hospital acquired heal pressure ulcers related to friction
and a significant impact on the patients’ health and wellbeing. and shear. The initiative led to an overall reduction of 84%. The
reduced incidence implies cost savings of £184,758 less the cost
of the booties and decontamination.

Pressure Care 7
WINNER In association with
Tissue Viability Team,

NHS Greater Glasgow
and Clyde
Describe the work you have done which has resulted in you winning a JWC award.
In 2014 NHS Greater Glasgow and Clyde made it policy for a mandatory referral to Tissue Viability
for all hospital acquired pressure damage. A tissue viability nurse (TVN) would review the patient and case notes to determine the
diagnosis, grade, using a dedicated review tool to determine if the pressure damage was avoidable or not. We analysed the data collected
from these reviews and discovered that the risk assessment tool and care planning were not conducive to robust risk assessment or
individualised care planning.
We developed our own tool called PUDRA – Pressure Ulcer Daily Risk Assessment. PUDRA is based on the evidence-based SSKIN bundle.
PUDRA also contains an individualised interventional care plan and guidance on how often care interventions should be carried out.
PUDRA underwent eight tests of change using Plan Do Study Act methodology and was finally rolled out a year ago. There has been a
dramatic reduction in hospital acquired avoidable pressure damage with one hospital showing a reduction from 95% to 0%. Pre and post
interventional results were significant (p<0.001).
Using the same approach, the tissue viability team in NHS Greater Glasgow and Clyde intend to tackle other issues. In this year’s work
plan we intend to look at moisture lesion prevention.
In NHS Greater Glasgow and Clyde the tissue viability team is valued for the contributions we make to patient care. I think winning this
award consolidates the good we are doing and gives recognition to our team.

Martina Tierney Emer Shanley
Occupational Therapist & Clinical Director, PhD Scholar, Royal College of
Seating Matters Surgeons in Ireland
Tierney has been the driving force behind Seating Matters In association with the Royal College of Surgeons in Ireland, I
research, partnering with leading researchers at Ulster developed and validated an instrument for the assessment of
University to conduct a clinical trial exploring the effectiveness patient knowledge, attitudes and behaviours. To date, no other
of specialist seating provision in pressure ulcer prevention. By such instrument exists. The KPUP is a rigorously developed reliable
using prescribed seating and applying The Four Principles of and valid instrument, which can be used in further research,
Pressure Management in Seating, pressure ulcer incidence was clinical practice and education to evaluate patients’ knowledge of,
reduced by 88.3%. Tierney and her clinical team work tirelessly and attitudes and behaviours towards pressure ulcer prevention.
disseminating these results through clinical training and sharing It is designed as a short tool for ease of administration and
knowledge on how to improve patient care using evidence- scoring, and could be used to evaluate the efficacy of educational
based practice. interventions in the field of pressure ulcer prevention.

Innovation in North America
Sponsored by
Ross Huntley
Director of Sales and Marketing, Advancis Medical

The complexities of our ever changing NHS system are understandably constantly high on
the agenda here in the UK, and as such so too is the amazing work by clinicians to adapt and
continue put the patient first. North America comes with its own very unique challenges
for clinicians and patients alike, and for Advancis Medical it is clear that despite the
complexities of health-care insurance, third party billers and more, the synergy in striving to
deliver outstanding patient care is something that needs to be promoted in order to share
best practice across a global market, and highlight the truly innovative work that is being
delivered in North America.

Whether industry or clinician we must challenge ourselves to innovate and adapt in order to
provide continual, quantifiable improvement in patient quality of life and patient outcomes.
Our hope is that this award will raise the profile, provide transparency and inspiration for
clinicians across North America to not only embrace the innovative ideas that are currently
being delivered and introduced by the likes of those shortlisted in this category, but
also inspire them to challenge themselves and their colleagues to continue to share the
unbelievable work that they do.
How will this award change people’s perception of research and innovation
in North America?
Rather than a need to change people’s perception, the key aim for us is to support clinicians
with the knowledge that whether it be new research, innovation in new treatments and
regimes, or indeed innovations in the effective management of transitional care, they are
not alone and that their work is hugely important not just to their patient cohort but to
their colleagues, and to the wound care community across the globe.
Embrace collaborative working with multiple stakeholders across multiple areas, and
engage in the new technologies and innovation that is continually being evolved. Delivering
improved patient outcomes and cost-effective wound management will be the focus of a
broad range of people across multidisciplines, and by engaging with these stakeholders you
will find that these common goals can be achieved.

WINNER
Mina Izadjoo, Hosan Kim,
Salman Izadjoo, Vanessa Marcel,
Huan Truong and Hans Kuhnlenz
Trideum Biosciences
I have been working in the infectious diseases field for more than two decades. My research has been focused on drug resistant
pathogens and their biofilms. We established testing methodologies and for the first time showed antimicrobial efficacy of a
pocket-size cold plasma technology. We successfully demonstrated antibacterial, antifungal and antibiofilm properties of this
novel wound care device. Although there are several technologies generating cold plasma, this technology is novel due to its size,
reduced cost, being portable with no requirement for any noble gas, and ease of application. This work will lead to additional
discoveries and recognition of the importance of non-drug based wound care technologies.
I strive to be an innovative researcher and try to find solutions that one day may save a limb or life. It is encouraging and
rewarding to see our work has been recognised by JWC, a visionary organisation and the leading source of up-to-date research
on wound care.
What advice would you give to wound-care practitioners and researchers aspiring to achieve positive change within the field?
Strive for learning and excellence; be innovative; adapt to changes; be informed about scientific gaps and clinical needs; be a
team player; be passionate about science; and understand critical importance of scientific ethics as you take your journey in
education, research or patient care.

David Armstrong Professionals
Professor of Surgery, University of
Arizona College of Medicine
Dedicated to
Quality Wound Care
David is a specialist in the diabetic foot. His group has long
Accepted by Catherine Milne
made the comparison between wounds and cancer. They have
now proffered the term ‘diabetic foot remission’ and have The Professionals Dedicated to Quality Wound Care developed
developed strategies to maximise ‘ulcer-free days’. This has three documents aimed at improving care transitions.
culminated in a paper accepted in the New England Journal · Patient Discharge Planning Form/Checklist
of Medicine ‘Diabetic Foot Ulcers and Their Recurrence’. · Provider to Provider Communication Form/Checklist
Their data make a strong case to consider a change in how we · Wound Care Flags Form—a teaching tool and a working
approach policy, resources, and care pathways not only to heal document for patient/significant others to use to monitor the
wounds, but to care for people who have healed for the rest of, wound, and alert them as to when potential complications are
what is hopefully, their long lives. starting to occur.

Best Laboratory/Preclinical Study
Sponsored by
PERFECTUS Samantha Westgate

BIOMED Director, Perfectus Biomed Ltd

The JWC awards support and recognise research that helps to improve wound care outcomes
and patient quality of life. Perfectus Biomed is proud to support this cause.
Why is it important for the JWC Awards to recognise excellence through the
Laboratory/Preclinical Study award?
Recognition of excellence in research raises the profile of the work and achieves wider
recognition of current laboratory studies and their implications in the clinical setting.

Excellent wound care is proactive, timely and effective, based on insight into the underlying
wound aetiology, a comprehensive understanding of the right options for care, and the
holistic path to full recovery for each patient.
How do you think this award will impact on practice and research in wound care?
By awarding and publishing high-quality research, researchers and practitioners are inspired
to excel and to set new standards for wound and patient care.
How has this award changed people’s perception of the role

of laboratory/preclinical research in wound care?
This award continues to draw attention to the importance of pre-clinical studies in addition
to clinical and case studies. The scientific rigour displayed by the winners of this award
helps to highlight how good pre-clinical data can answer important questions regarding the
complex world of chronic wound care.
What advice would you give to clinicians and researchers aspiring to achieve
positive change within their role?
While learning and adopting best practices yourself will achieve positive change,
capturing that learning and adopting this within the professional education of others will
multiply the impact. As such, when you are armed with new and better insight, assisting
in the professional education of others may often be the most effective way to achieve
positive change.

7
WINNER
Dilip Thomas
Postgraduate Researcher, Centre for Research in Medical
Devices, NUI Galway
My preclinical research is centred around the development and testing of a biomaterial-based
stem cell delivery device as a therapeutic strategy for ‘no option’ Critical Limb Ischaemia
(CLI) patients. CLI patients, due to the lack of sufficient blood supply, suffer from non-healing
ulcers and tissue damage, which further leads to foot amputation in a third of the patient population. In order to enhance the
therapeutic efficacy of stem cells, cells were encapsulated in collagen ‘microgels’—to promote high cell survival and retention. I
demonstrated that tuning the properties of the microgels prime and enhance the angiogenic capacity of stem cells via paracrine
release of trophic factors when delivered to an ischemic, slow healing wound.
The recognition of my work by the JWC highlights the impact of research to health professionals, translational scientists and peers in
the area of wound care. The award also certifies a high standard based on the quality of work to obtain further funding from research
agencies. From the research and translational standpoint, future work will focus on understanding the mechanism of action while
compiling safety and toxicology data for the first-in-human clinical trial.

One of the major challenges was pertaining to the development of a preclinical animal model and its relevance to the
pathophysiology of CLI observed in humans. Even though the animal models will never match the comorbidities of human
diseases, reproducing the most relevant clinical symptoms and defined study end-points can provide meaningful indicators of an
effective therapy.

Cornelia Wiegand Ruben Vellettaz
Scientist, Universitatsklinikum Jena, Germany MD, Clinica Colon, Argentina
Wiegand has been working on laboratory tests that help to Vellettaz and team generated an autologous bilayers skin
identify pathogens that cause wound infection. Her work on substitute in a three-dimensional fibrin matrix, intelligently
antiseptics, fluid management systems and negative pressure produced by Tissue Engineering. The structural and
have been the subject of many publications and presentations. ultrastructural features were compatible with skin grafting,
Wiegand has an amazing skill for devising new laboratory proving effective in the treatment of surgical wounds induced
methods and applying them to practical solutions. The in a porcine model.
balance between being a ‘pure’ scientist and understanding
the relevance to the patient and clinician is a rare talent, and
Wiegand has this insight which clearly shows in the prolific
work that she does, individually and as part of a team.

Clinical Research
Sponsored by
Lorraine Grothier
Head of Clinical Services, Urgo Medical
Why did you support this Award?

Urgo Medical is committed to invest in the development of clinical research to support
their products to ensure effective outcomes for patients with wounds. Therefore it would
seem appropriate that Urgo support an awards which encourages innovation and excellence
in clinical research.
Why is it important for the JWC to recognise excellence through the Clinical
Research award?
Clinical research can be costly both in terms of resource and time. It takes dedication and
commitment from the individuals involved but it is usually driven by a passion and the
desire to find answers and solutions to clinical issues. Giving recognition to those who
undertake clinical research not only offers some reward for their efforts but allows them to
share what they have learnt and may help to inspire others to implement their findings or
contribute towards the body of evidence.

Excellence in wound care can be defined as always striving to seek out, understand and
apply the best available evidence to clinical practice. By doing so this will achieve the best
possible clinical outcome for the patient.
By studying and identifying the risk factors for surgical site infection (SSI) in this patient
group and the associated costs, this research allows clinicians to be proactive with
regards to patient safety. This will lead to new protocols to reduce risk and improve
patient outcomes.
Identify the gaps in your knowledge and/or practice which can potentially lead to positive
change in that area. Don’t work in isolation, working with specialists and multidisciplinary
teams can provide you with greater insight into what is possible and achievable as well as
providing a sounding board and support for new ideas. Finally, make sure you communicate
with all the stakeholders involved.

7
WINNER
Ross Atkinson, Anna Jones,
Karen Ousey & John Stephenson
The University of Huddersfield
In patients who underwent spinal surgery, using advanced statistical methods, we
found: an increased risk of SSI in those whose operation involved greater numbers
of vertebral levels (odds of SSI increased by 26% for each additional level involved); controlling for number of vertebral
levels, odds of SSI increased by 5.6 in those having surgery primarily on the thoracic spine. We also aimed to determine:
whether SSI had any impact on patient survival; and the main interventions (and associated costs) used to manage SSI.
We conducted a survival analysis showing that life expectancy is 141 days shorter in SSI patients than non-SSI patients;
corresponding to 34.5 years of life lost nationally per year. The analysis of SSI management and related costs in this
patient group determined that hospital stay is around 90% longer in patients with SSI. Around 23.5% of patients required
re-operation on 1-10 occasions. Increased hospital stay and return to theatre accounted for almost all SSI-related costs;
2.5 times those of non-SSI patients, excluding costs of community care, and individual and societal costs.
We hope that the evidence from these studies may raise awareness of the importance of SSI as a complication of
surgery for spinal metastasis and the procedural factors which are significantly associated with its occurrence.

One of the most important aspects of our work is to undertake research that has a direct relevance to clinical practice.
Our work shows that patients who develop an SSI are more likely to need longer in-hospital stays, and to die earlier. In
patients with already limited life expectancy, SSI can truly be a devastating complication.

Martina Tierney Andrea Mahon
Occupational Therapist & Clinical Director, Doctoral Researcher in Podiatric
Seating Matters Medicine, National University of
Ireland Galway
To date, there has been little research to determine how
detrimental poor seating is on pressure ulcer development. The Podiatry Diabetes Education Model (PODIEM) Trial seeks
Tierney conducted a clinical trial with Ulster University to examine education and support in wound prevention, using
that explored the effectiveness of specialist seating three cornerstones of intervention evaluation—systematic
provision in the prevention of pressure ulcers. The results review, expert analysis and randomised controlled trials.
showed using prescribed seating reduced pressure ulcers The trial is the first long-term study amalgamating the
by approximately 88 %. current literature, expert opinion and patient experience
with quantifiable and objective research outcomes to assess
therapeutic efficacy of mobile health applications in diabetic
wound prevention.

Patient
Patient Wellbeing
Wellbeing
In association with
Ellie Lindsay
Founder of The Lindsay Leg Club

Patient wellbeing is at the heart of the Leg Club philosophy so we were naturally
delighted to participate in the presentation of the 2017 JWC Ppatient Wellbeing award.
Why is it important for the JWC to recognise excellence through this award?
This award celebrates collaborations between clinicians and academic colleagues who have
initiated interventions to measure and articulate explanations for wellbeing, exploring
and documenting how this knowledge can be used to enhance patient care and the
psychological wellbeing of those living with lymphoedema and/or wounds.

Sound research, best practice and innovation underpin excellence in wound care,
enabling significant positive change, demonstrated through evidence of enhanced
patient outcomes. It is often a team effort involving collaboration between different
disciplines developing creative ideas within an evidence-based framework.
These awards enable clinicians and academics to raise the profile of innovation. By
disseminating and publishing findings, recipients of the JWC awards can promote new
concepts and present evidence of enhanced patient experiences more widely within the
wound care and health care communities.
How does this award change people’s perception of the role of patient wellbeing?
Research has demonstrated the importance of social interaction on both wellbeing and
wound healing, clearly demonstrating the importance of promoting self-empowerment
which ultimately leads to improved patient adherance, better healing rates and overall
outcomes. Beneficiaries of these awards have initiated many interventions to measure
and enhance wellbeing.
In today’s fiscal climate NHS providers tend to focus on wound healing as a key outcome
measure for patients. While this is clearly very important, a focus on the patients’ quality
of life tends to get left behind. Therefore, it behoves clinicians and researchers to be
entrepreneurial in their approach to wound management while maintaining the emphasis
on the ultimate goal of patient wellbeing. Effecting change inevitably requires collaboration
at various levels—communicating ideas and strategies and potentially sharing values,
planning, action and reflection. Always remember as professionals striving to bring about
change to achieve your aspirations it is always necessary to unite and work in partnership
with various disciplines and organisations—not in isolation!

7
WINNER
Anne Williams
Lymphoedema Nurse Consultant and Lecturer, Queen
Margaret University, Edinburgh
I was honoured to win the Patient Wellbeing award this year. I have worked with people who have
lymphoedema, lipoedema and leg ulceration for over 20 years. The lymphatic system and related
conditions such as lymphoedema and lipoedema are poorly understood, and this has driven
my passion for developing services and establishing a better evidence base through research. I won the award for my contribution to
person-centred NHS and third sector service developments—from London to the Highlands of Scotland—and my contribution as
a researcher and educator. My research focus has included: the science of compression therapy; manual lymph drainage; supported
self-care; and patient experiences. This has enabled me contribute to a wide range of patient-focused activities in the UK and Europe,
including co-chairing the development of a recent Best Practice Guideline in the Management of Lipoedema.

Working as an educator, in its broadest sense—whether with patients, clients or students. Providing the resources and support that
empowers others to make positive changes in their life.

The fact that my days can be very varied—from teaching applied biosciences to undergraduate nursing students, supervising a PhD
student, running a lymphoedema self-management course, or working with a group of nurses and massage therapists to learn a
new skill, such as Tripudio, an exercise and movement programme.

Lack of time to do everything I would like—such as writing papers and research grant applications!

Helen Cowan Dr Moses Murandu
Nurse, Order of St John Care Trust Senior Lecturer, University of
Wolverhampton
Writing for the world-renowned medical blogging site
‘Hippocratic Post’ Cowan gave an overview of the enormous Murandu work using granulated sugar for the management of
variety of wounds experienced by patients: from deep sternal necrotic exuding wounds commenced in February 2009 as a
wound infections (treated by negative pressure wound therapy) pilot study, following which there was a randomised controlled
to necrotic stumps (treated by maggots) and chronic leg ulcers. trial from June 2010 till June 2013. The results were promising
Cowan unashamedly described the pain experienced, the therefore Murandu designed a trial using Telemedicine to help
gruesomeness of some wounds, the odour and the fact that informal carers manage their relatives’ wounds in Botswana and
some wounds take years to heal. Doctors and nurses who read Zimbabwe. The results were all six patients healed.
this important article will have more empathy and insight to
the patient experience regarding wound care: http://www.
hippocraticpost.com/call-of-duty/colours-wound-care.

Compression Therapy for Venous and Lymphatic Disorders
WINNER
Healogics Team
Crawley, Horsham and Mid-Sussex
This is a team nomination for a venous leg ulcer/chronic oedema service providing care
across five different locations for 4 years. Our approach is to establish an accurate diagnosis
and engage with the patient and their carers to provide the most efficacious compression
therapy as quickly as possible. We prioritise building a therapeutic relationship with the
patients and their carers to ensure high levels of adherence. The team use a variety of compression methods based on
pathways and an educational assessment of the patient. The nurse-patient therapeutic relationship is based around continuity
of care, shared decision making and education. Our lead nurses are trained in both lymphoedema and tissue viability which
allows them to choose the best possible pathway to treat the oedema present based on national and best practice guidelines.

The positive outcomes that we experience; the service has healing rates of 100% on Pathway 1 (simple) at 12 weeks and 86%
at 12 weeks for pathway 2 (complex). The results indicate that this process driven, patient-centred approach can result in high
levels of patient matched by high levels of healing well over the national average. Ultimately, we feel our service makes an
impact upon our patients and their families, healing long standing leg ulcers is life changing.

The main challenges are those related to previous treatments and care that patients have experienced which can make it
difficult to develop a concordant and effective therapeutic relationship. Our high concordance rates of 87–99% hopefully
demonstrate that our approach builds trust with the patients and encourages them to believe healing is achievable when
perhaps they had previously lost faith.

Rebecca Elwell Jacky Edwards
Macmillan Lymphoedema ANP, Royal Stoke Burns Nurse Consultant, University Hospitals of
University Hospital South Manchester NHS Foundation Trust
Elwell and colleagues set up an expert lower limb group to Edwards has demonstrated the effectiveness of introducing
create work streams for cellulitis, deep vein thrombosis (DVT) compression therapy for the management of patients with
and leg ulceration. Currently the streams for cellulitis and burns to their lower legs. This protocol has been incorporated
DVT have been agreed in place and continually monitored into a Chronic Burn Management Pathway and as community
by group members. The leg ulceration pathway is in the pilot nurses are familiar with compression they are happy to manage
stage with steps to underpin knowledge across the trust burn patients with the therapy.
before a full roll out. These streams have reduced duplication
of care, streamlined the patient journey and improved patient
experience. The development of the clinically led expert lower
limb group has allowed reflection on the things we do well and
how we can develop this to benefit all.

Professional Education 7
WINNER
Kevin Woo
Assistant Professor & Advanced Wound Consultant, Queen’s
University, Canada
The management of diabetic foot ulcers (DFUs) requires comprehensive and lifelong behavioural
modifications that entail regular foot care, exercise, dietary changes, smoking cessation, and
frequent blood glucose testing. I am leading a research team at Queen’s University to develop
an online support group, a ‘foot club’, for people with DFUs, to promote chronic disease self-management and treatment adherence.
The innovative use of social media has the potential to widen access of health information and make contact with populations that are
hard to reach or isolated because of their geographical location, cultural dispositions, and socioeconomic status. In partnership with the
Canadian Association of Wound Care and Canadian Diabetes Association, we envision the online platform to be an ideal conduit for
knowledge transfer to people with diabetes and potential health-care providers.  
I am so thrilled and honoured to be the recipient of this award. This award has motivated to me to work harder and be more
patient centred! My overall research objective is to address the health needs and safety of the frail older population with chronic
and complex conditions, especially those with chronic wounds. Integral to my programme of research are projects that will explore
strategies to promote chronic disease management. I am currently undertaking a project to examine health service use among
people with diabetes and first amputation. I am also very fortunate to work with the International skin tear advisory panel (ISTAP)
to explore ways to address education in skin tears.
I got a call from my director and dean congratulating me on my achievement.

Martina Tierney Karen Ousey, Jeanette
Occupational Therapist & Clinical Director, Milne, Leanne Atkin,
Seating Matters
Valerie Henderson
Showing that correct seating can reduced pressure ulcer and John Stephenson
formation Tierney wanted to educate clinicians about this.
Derived from her research, Tierney authored the globally The team has developed, implemented and commenced
respected ‘The Clinician’s Seating Handbook’ a resource which evaluation of the first UK wide Tissue Viability Service
has been distributed to clinicians worldwide. Tierney’s desire Competency Framework - Tissue Viability Leading Change
to educate and change the way people think about seating (TVLC). They have demonstrated that tripartite working
is infectious and she has travelled the world sharing her between academics, key opinion leaders and industry can
knowledge and passion for pressure care. positively benefit health professional education in an effective
and cost-effective manner. TVLC is a free resource that is
updated annually to maintain its relevance.

Innovation Award
In association with
Jackie Stephen-Haynes
Chair Wound Care Alliance UK

The Wound Care Alliance (WCAUK) is committed to the provision of education and
educational resources to support the delivery of appropriate evidence-based clinical care.
Innovation, a new idea, device or method is the application of better solutions and is often
something original and more effective. New ways of thinking are important for the on-going
development of care delivery. Therfore the WCAUK is pleased to support an award that
recognises excellence through innovation.
Why is it important for the JWC to recognise excellence through the Innovation Award?
Innnovation occurs when people are prepared to view new solutions to existing challenges.
They often require thinking differently and having the courage of your convictions to
investigate the innovation and to implement.
Every 20 seconds somewhere in the world, a limb is amputated as a result of diabetes. The
ability to predict the formation of diabetic foot ulceration, to enable their early detection and
support the delivery of more effective clinical and financial outcomes is essential for the care
of patients at risk of or presenting with a diabetic foot ulcer. A new innovation can also act as
a spring-board for further research. The use of scanning and the cloud for data analysis and an
innovative algorithm has the ability to implemented nationally and even internationally.
The way to making change is by making choices and to secure support to manage the
change. Procrastination occurs when the challenge is greater than our energy, so working as
a team (Team remember Together Everyone Achieves More) is essential. Positive change may
of course be the right thing to do, but that doesn’t make it easy. So allow yourself some
thinking time and spend time really thinking about what you want to achieve and why you
want to achieve it. Think about who are the people that can support you or why you can
work in partnership with. Remember that positive change requires someone to start and
someone to follow. So garner support and think of those that might try to sabotage your
idea and what you can do to avoid this. Develop the ability to articulate clearly what the
positive change can achieve or help you to acvhieve. A briefing paper might also be needed
and if necessary get support with this. Share and celebrate the small successes, these can
inspire others to work with you!

7
WINNER
Chris Murphy
CEO, Bluedrop Medical Thomas
Diabetic foot ulcers often take months to heal and if not treated early can result in amputation
and may even be life threatening. Bluedrop Medical is developing a device that takes a daily scan
of the soles of a diabetic patient’s feet, taking the form of a bathroom scales. If an active ulcer
or the pre-signs of ulceration are detected the patient and their clinician are notified, allowing
for the earliest possible intervention. Bluedrop Medical’s device builds upon research proven to prevent up to 70% of
ulcers in high risk diabetes patients. High risk patients have up to a 30% rate of ulceration per year and 84% of all diabetic
foot ulcers come from this group. There is therefore a highly-targeted population that would benefit from this system.
External validation is always important, especially when developing a new product. Winning this award will undoubtedly
positively impact the perception of our organisation to the clinical community.

At Bluedrop Medical, our mission is to develop innovative products in the field of diabetic foot ulcer prevention. The
most important aspect of this task is to develop a deep understanding of all stakeholders. These stakeholders include
wound care practitioners, patients, administrators, researchers and health-care payers. Our team has conducted weeks
of clinical immersion in podiatry clinics specialising in the treatment of diabetic foot disease. We have also conducted
in-depth interviews and focus groups with over 100 stakeholders. This has given us a broad insight into the problem and
a how we can deliver the biggest impact.

Clare Morris Jacky Edwards
Clinical Services Manager, Activa Burns Nurse Consultant, University Hospitals of
Healthcare South Manchester NHS Foundation Trust
Morris realised there was a lack of understanding around Edwards introduced compression therapy for the management
pressure ulcer categoreisation and felt there was a need for of patients with burns to their lower legs. There is no published
fun, interactive and effective education in area. She used evidence of this therapy being used in either new or chronic
gamification of learning, an educational approach to motivate burn wounds. Over the past 2 years Edwards has seen 30+
students to learn by using a game design, and developed a cases demonstrating its effectiveness in this patient cohort.
board game called ‘Under Pressure.’ She has since been able This protocol has been incorporated into a Chronic Burn
to share this with TVNs, general community and acute-based Management Pathway.
nurses across the country who have reported good retention
of information and new knowledge in this subject, making a
‘dry’ and ‘wordy’ subject fun and memorable.

Veteran and Military Wound Care
Supported by
Claire Stephens
Founder and Chief Executive Officer, Woundcare4Heroes UK
Why did you support this Award?

Woundcare4Heroes as a registered veteran wound care charity has supported this award
category to recognise research, knowledge, skill and dedication of wound care practitioners
both military and civilian currently supporting those injured during military service. The
media spotlight is no longer focused on our military injured and as such the importance
of maintaining awareness of this population’s ongoing needs and further driving the
development of specialist wound care services is high priority for Woundcare4Heroes.
The wound care journey following traumatic or service related injury is life long and the
needs are often varied and complex in nature, frequently stepping outside the parameters
of ‘normal’ wound care practice. Access to transitional and life-long specialist wound care
services, support services and education are paramount to ensure positive and timely
outcomes for our veteran community. This award serves to recognise all practitioners
pushing the boundaries of wound care practice, research, audit and ongoing service
development in the field of military and veteran trauma aftercare.

Excellence in post traumatic military and veteran wound care can be defined as the
development of life and limb saving medical procedures, easily accessible ongoing
multidisciplinary specialist service provision, positive wound healing outcomes, continued
limb or tissue salvage, hospitalisation prevention and wound prevention, service user
satisfaction, access to advice, support and education while being cost-effective and
underpinned through research and audit.
We are hopeful this award category will stimulate health practitioners in the future to look
at the services they currently offer for the traumatically injured veteran community within
their area and assist in the identification of new methodologies to continue to improve the
services we are able to deliver through practice-based research.
The ability to improve traumatic wound aftercare services exists for all patients through the
cross pollination of knowledge and skills deeming the potential impact on practice as far
wider reaching than the veteran community.
How has this award changed people’s perception of the role of military wound care?
Wound care procedures and practice developed through our military practitioners during
times of conflict have significantly helped to shape trauma after care wound practice within
our NHS generally and the importance of capturing this legacy cannot be understated.
In general, people’s perceptions are changing and the realisation of the need for specific
tailored services and life-long care pathways is now well accepted.

7
WINNER
Reza Jafari
Lymphoedema Therapist, Woundcare4Heroes UK
I’m so humbled to have been chosen for this award. It’s a tremendous honour to be
acknowledged by such an esteemed journal. Since I joined Woundcare4Heroes, I have been
treating veterans of our armed services who suffer from lymphoedema. These patients present
a varied and complex set of functional impairments with moderate to severe oedema as well as
secondary neuromusculoskeletal disorders resulting from oedematous conditions. We are a dedicated team who are committed
to offering our veterans multidisciplinary specialist care and comprehensive rehabilitation programme. The nature of my role
is collaborative and I interact with various stakeholders. This award is a recognition of my continuous efforts to take a holistic,
individualised and flexible approach in addressing the physical, emotional and mental needs of our veterans. Winning this award is
also a recognition of the expertise of our team in the innovative thinking and development of leading-edge solutions in the fields
of wound care and lymphology.
With recognition comes responsibility and the chance to be more influential to find new avenues to make a positive difference to
the veterans’ lives. I am now honour-bound to fulfil my duties with more passion, diligence and integrity.

The most important aspect of my work is to make sure that veterans are involved in and central to their care. This means
considering patients’ aspirations, goals, values, family situations, social circumstances and lifestyles at the centre of decisions
and working alongside other health professionals to get the best outcome. Patient-centred care is therefore a key component
of developing and delivering high-quality healthcare, because it not only develops appropriate solutions, but it also produces
knowledge that is accessible.

Justine Whitaker Paul Watson
Director & Nurse Consultant, Military Children & Young Carers
Northern Lymphology Ltd & Consultant, Teeside
Senior Lecturer, University of Central Lancashire
Watson has been instrumental in developing the Military
Whitaker’s was nominated for her drive, commitment and Children & Young Carers Consultancy. This specialist area of
charity support services for lymphatic compromised post- caring for military children and young people is often forgotten
traumatic or service related injured armed forces veterans and families find it difficult to access support. The consultancy
within the UK. She has initiated and maintained a bespoke provides strategic planning and service implementation,
charitable lymphatic service for wounds which has now been national project coordination and professional training to
running for over 2 years and has seen Whitaker providing improve the lives of military dependant children, young people
consultant assessments, developing care pathways and training and young carers.
local practitioners from coast-to-coast to provide lymphatic
management to the veteran community.

Innovative
Innovative New
New Dressing
Dressing
WINNER
HydroClean Plus
PAUL HARTMANN Ltd
Describe the work/application/evidence which has resulted in this dressing winning

the award
In 2016 HydroClean Plus was launched in the UK. This dressing was developed by HARTMANN
to enable autolytic debridement and wound bed preparation/healing. The dressing,
based upon a superabsorbent, delivers/absorbs moisture via a combination of the fluid
management properties of the SAP and the “activation” of the SAP with Ringer’s solution. The latter released
into the wound bed enabling autolytic debridement supporting the detachment of necrotic tissue and fibrinous
slough. At the same time, bacteria/protein-laden wound exudate is absorbed into the dressing’s absorbent
core, binding it away from the wound surface thus effecting a dual purpose modality that aids debridement and
importantly wound bed preparation. UK clinical studies have shown HydroClean Plus to be effective at debriding/
desloughing many wounds using the body’s own ‘safe’ and painless mechanism of autolysis. Outcomes of these
studies support the use of HydroClean Plus in wound bed preparation in accordance with TIME. Importantly
results have demonstrated highly successful debridement in a rapid, painless and cost-effective manner and that
the hydrated environment provided also enables healing progression. For the clinician this product simplifies the
decision-making process allowing them to choose a product that enables positive wound care outcomes that
benefit both the patient and clinician.
How will winning the award influence the future direction of your work?
HydroClean Plus is part of a sequential wound treatment solution called HydroTherapy. This award will highlight
the use of HydroTherapy (HydroClean Plus for wound bed preparation and HydroTac to boost epithelialisation
in terms of the positive benefits that it can bring. As such more practitioners will become aware that there are
simpler and less painful wound debridement options that are as/or more effective than current treatments.

Biatain Silicone UrgoClean Ag
Coloplast Urgo
Biatain Silicone is designed according to the Coloplast UrgoClean Ag is an innovation in silver dressings since as it has
Design DNA. This means users will experience an intuitive the cleaning power to fight local infection. Launched in 2016 it
and non-medical looking product with a fresh, lifestyle- has antibiofilm efficacy providing a complete cleaning action of
oriented design. Intuitive and aseptic application potentially the wound bed. It reduces the bacterial load within the wound
minimises the risk of contamination while applying the through a fast and broad-spectrum antimicrobial efficacy,
dressing. The 3-piece non-touch is designed for just that, as including bacterial strains resistant to antibiotics.
it communicates easy opening and handling of the product,
it also reduces the risk of infection from fingers or gloves
touching the wound or dressing. Biatain Silicone is designed
in a cool grey colour. An honest and demystifying colour
because it does not try to imitate the skin colour as this
seems to fail more often than succeed.

Innovative
InnovativeNew
NewProduct
Product 7
WINNER
Lundatex system
PressCise AB
Describe the work/application/evidence which has resulted in this product winning

the award
Our bandage is the result of a collaboration between a mathematician, a surgeon and a textile
developer. The surgeon, Dr Erney Mattsson, saw an unsolved problem with the bandage
he used in his practice and the mathematician, Torbjörn Lundh, solved the problem with a
mathematical formula. The mathematical formula was handed over to Josefin Damm who interpreted it into a textile.
The developed bandage is highly elastic and gives a precise pressure to any leg, independent of the size and shape and
who applies it. In our two-component compression product Lundatex system, we add in-elastic velcro patches to the
bandage which create a stiff shell around the leg. While the bandage ensures a low and comfortable resting pressure,
the shell raises the working pressure. The elevated working pressure supports the calf muscle pump and thus drastically
increases the venous return.
The Lundatex system is made to fit any leg. The bandage is built to give same pressure on any sized leg and the stiff
shell is custom made directly on the patient.
How will winning the award influence the future direction of your work?
We hope that this will open up many eyes to pressure controlled compression treatment. The fact that the award
comes from Journal of Wound Care, a journal written for our main target group, gives us confidence that our
product is appreciated by the medical world. This of course gives us an extra push when it comes to getting our
product out on a bigger market, and takes us one step closer to our mission of pressure controlled compression
treatment for every patient!

Adtec Steriplas BRH-A2
Gas Plasma Jagmed Ltd
Adtec The BRH system is a unique treatment combining ultrasound
Adtec SteriPlas Gas Plasma technology is a novel innovative and electro-stimulation to heal chronic wounds. The software
use of energised gas as a topical antimicrobial in infection modulates the frequency and intensity of both modes to
management. The technology was developed in collaboration create resonance within the tissue for the entire length of each
with the Max Planck Institute and is supported by over treatment. This creates a ‘microcirculation’ effect within the
9 years of scientific and clinical research with leading research tissues and blood vessels increasing the blood flow to improve
organisations in Europe. With a physical mode of action, healing rates. The treatment has also been shown to reduce
microbial resistance is unlikely and gas plasma has proven pain and increase patients’ quality of life. The system has in-
efficacy against all pathogenic bacteria including antibiotic- built patient management software to track patients’ progress.
resistant bacteria. The technology has now been adopted Clinicians can add pictures of the wounds using the provided
for use as standard infection management in wound care and camera and can use the system to calculate the surface area of
surgical site infections in hospitals in Europe. the wound.

Best Research from a Developing Country
WINNER
Moses Murandu
Senior Lecturer, University of Wolverhampton
Describe the work you have done, which has resulted in you winning the JWC
2017 Best Research in a Developing Country
Winning this award is a great personal honour. My work using granulated sugar for the
management of necrotic exuding wounds commenced in February 2009 as a pilot study which
lead to a randomised controlled trial. The results were promising therefore a trial of using
Telemedicine to help informal carers manage their relatives’ wounds in Botswana and Zimbabwe was undertaken. The
wounds of all six patients treated by this method have healed.
The Award has sparked an interest from industry that certain business individuals are mobilising to invest into this work.
The award has increased the credibility of my work. The Vice Chancellor and the Dean of the Faculty at the University of
Wolverhampton are very pleased as this increased the research image within the university.

To me, the most important aspect is improvement of the quality of life of patients and the non-use of antibiotics. The
method is user-friendly, and can be applied by either professionals or informal carers. Training and wound progress can be
done and monitored easily via Telemedicine in the UK as per this pilot study.

Ruben Vellettaz Basavraj Nagoba, Rajan
MD, Clinica Colon, Argentina Gandhi, Arunkumar Rao
Vellettaz and team are nominated for their work creating an
Depts. of Microbiology, Surgery & Orthopedics,
autologous bilayers skin substitute in a three-dimensional MIMSR Medical College, Latur, India
fibrin matrix, intelligently produced by Tissue Engineering, The team worked on a newer approach for the treatment of
which can be produced on a large scale and is now in pilot wound infections caused by antibiotic-resistant bacteria. Our
study approved by the national regulatory authority to team has successfully developed treatment modality for a
evaluate these tissue engineering techniques in chronic variety of infected wounds such as diabetic foot infections,
venous ulcers resistant to conventional treatment. leprosy ulcers, burns infections, non-healing ulcers and
postoperative wound infections, by using citric acid ointment
(prepared using petroleum jelly as a base) as a sole topical
antimicrobial agent. The results confirmed that polylactic
acid-based wound dressing has the essential functional
properties required to enhance wound healing.

7
For sponsorship please contact

Anthony Kerr on +44 (0)20 7501 6726/
+44 (0)7979 520828, or email at
anthony.kerr@markallengroup.com
For award queries please contact Rachel Webb

rachel.webb@markallengroup.com

7
The Award Winners 2017
Sponsored by
PERFECTUS
BIOMED
The Journal of Wound Care would like to thank all sponsors and supporters for participation in the JWC Awards 2017

Winners Supplement

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Winners Supplement

Hochgeladen von

Copyright:

Verfügbare Formate

7

The Award Winners 2017

The Banking Hall, London

Printed by: Pensord, Blackwood, Newport, Wales, UK

Tel: +44 (0)20 7738 6726 Email: anthony.kerr@markallengroup.com Web: www.markallengroup.com

2 JWC The Awards 2017

JWC The Awards 2017 3

Official journal of the World Union of Wound Healing Societies

The role of resilience in rebuilding lives

JoWC_2016_25_10_cover.indd 1 20/09/2016 16:38

THE ONLY MONTHLY INTERNATIONAL JOURNAL OF WOUND CARE

ORIGINAL EVIDENCE-BASED PROSPECTIVE LATEST

Visit www.magsubscriptions.com/jwc or call 0800 137 201 (UK ONLY)

This year’s ceremony, held at the prestigious Banking Hall,

For this year’s 15 categories we received a record number of

Congratulations to all the well-deserved winners on the night and

I hope to see you all there.

JWC The Awards 2017 5

Why did you support this award?

What do you think defines excellence in wound care?

6 JWC The Awards 2017

What do you most enjoy about your work?

SECOND PLACE THIRD PLACE

JWC The Awards 2017 7

What do you think defines excellence in wound care?

8 JWC The Awards 2017

What is the most important aspect of your work and why?

What are the main challenges you face?

SECOND PLACE THIRD PLACE

JWC The Awards 2017 9

What are the main challenges you face?

SECOND PLACE THIRD PLACE

10 JWC The Awards 2017

WINNER In association with

Tissue Viability Team,

SECOND PLACE THIRD PLACE

JWC The Awards 2017 11

Why did you support this award?

What do you think defines excellence in wound care?

12 JWC The Awards 2017

SECOND PLACE THIRD PLACE

JWC The Awards 2017 13

PERFECTUS Samantha Westgate

Why did you support this award?

What do you think defines excellence in wound care?

How has this award changed people’s perception of the role

14 JWC The Awards 2017

What are the main challenges you face?

SECOND PLACE THIRD PLACE

JWC The Awards 2017 15

Why did you support this Award?

What do you think defines excellence in wound care?

18 JWC The Awards 2017

What is the most important aspect of your work and why?

SECOND PLACE THIRD PLACE

JWC The Awards 2017 19

Why did you support this award?

What do you think defines excellence in wound care?

20 JWC The Awards 2017

What is the most important aspect of your work and why?

What do you most enjoy about your work?

What are the main challenges you face?

SECOND PLACE THIRD PLACE

JWC The Awards 2017 21

2 JWC The Awards 2017

JWC The Awards 2017 3

JWC The Awards 2017 5

6 JWC The Awards 2017

JWC The Awards 2017 7

8 JWC The Awards 2017

JWC The Awards 2017 9

10 JWC The Awards 2017

JWC The Awards 2017 11

12 JWC The Awards 2017

JWC The Awards 2017 13

14 JWC The Awards 2017

JWC The Awards 2017 15

18 JWC The Awards 2017

JWC The Awards 2017 19

20 JWC The Awards 2017

JWC The Awards 2017 21

22 JWC The Awards 2017

JWC The Awards 2017 23

24 JWC The Awards 2017

JWC The Awards 2017 25

26 JWC The Awards 2017

JWC The Awards 2017 27

28 JWC The Awards 2017

JWC The Awards 2017 29

30 JWC The Awards 2017

JWC The Awards 2017 31